Drugs / Genistein Combined Polysaccharide
Genistein Combined Polysaccharide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00584532 Comparator | Nov 2003 → Dec 2005 | prostate cancer | University of California, Davis | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Genistein Combined Polysaccharide | “Genistein Combined Polysaccharide (GCP)” NCT00584532 ↗ |
| Known as | GCP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00584532 ↗ |
| Known as | Genistein Concentrated Polysaccharide | “Genistein Concentrated Polysaccharide (GCP)” NCT00584532 ↗ |
| Route | Oral | “given orally per day” NCT00584532 ↗ |